Placebo Eye Drops
Placebo Eye Drops is a pharmaceutical drug with 15 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
6
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
10 of 10 finished
0.0%
0 ended early
4
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
RCI001 Eye Drops 0.25% in Healthy Adult Male Participants
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)
Efficacy and Safety of VMX Eye Drops for Dry Eye Disease
Clinical Trials (15)
RCI001 Eye Drops 0.25% in Healthy Adult Male Participants
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)
Efficacy and Safety of VMX Eye Drops for Dry Eye Disease
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
A Study of TRS01 in Participants With Post-surgical Ocular Inflammation
Dose-Ranging Study of the Bimatoprost Ocular Insert
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin
Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
All 15 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 15